↓ Skip to main content

Cost-utility analysis of a preventive home visit program for older adults in Germany

Overview of attention for article published in BMC Health Services Research, April 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-utility analysis of a preventive home visit program for older adults in Germany
Published in
BMC Health Services Research, April 2015
DOI 10.1186/s12913-015-0817-0
Pubmed ID
Authors

Christian Brettschneider, Tobias Luck, Steffen Fleischer, Gudrun Roling, Katrin Beutner, Melanie Luppa, Johann Behrens, Steffi G Riedel-Heller, Hans-Helmut König

Abstract

Most older adults want to live independently in a familiar environment instead of moving to a nursing home. Preventive home visits based on multidimensional geriatric assessment can be one strategy to support this preference and might additionally reduce health care costs, due to the avoidance of costly nursing home admissions. The purpose of this study was to analyse the cost-effectiveness of preventive home visits from a societal perspective in Germany. This study is part of a multi-centre, non-blinded, randomised controlled trial aiming at the reduction of nursing home admissions. Participants were older than 80 years and living at home. Up to three home visits were conducted to identify self-care deficits and risk factors, to present recommendations and to implement solutions. The control group received usual care. A cost-utility analysis using quality-adjusted life years (QALY) based on the EQ-5D was performed. Resource utilization was assessed by means of the interview version of a patient questionnaire. A cost-effectiveness acceptability curve controlled for prognostic variables was constructed and a sensitivity analysis to control for the influence of the mode of QALY calculation was performed. 278 individuals (intervention group: 133; control group: 145) were included in the analysis. During 18 months follow-up mean adjusted total cost (mean: +4,401 EUR; bootstrapped standard error: 3,019.61 EUR) and number of QALY (mean: 0.0061 QALY; bootstrapped standard error: 0.0388 QALY) were higher in the intervention group, but differences were not significant. For preventive home visits the probability of an incremental cost-effectiveness ratio <50,000 EUR per QALY was only 15%. The results were robust with respect to the mode of QALY calculation. The evaluated preventive home visits programme is unlikely to be cost-effective. Clinical Trials.gov Identifier: NCT00644826 .

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 2%
Spain 1 <1%
Austria 1 <1%
Unknown 116 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 17%
Researcher 18 15%
Student > Ph. D. Student 15 12%
Student > Bachelor 10 8%
Student > Doctoral Student 5 4%
Other 21 17%
Unknown 32 26%
Readers by discipline Count As %
Nursing and Health Professions 23 19%
Medicine and Dentistry 23 19%
Social Sciences 7 6%
Economics, Econometrics and Finance 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 23 19%
Unknown 35 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2015.
All research outputs
#12,606,460
of 22,799,071 outputs
Outputs from BMC Health Services Research
#4,075
of 7,629 outputs
Outputs of similar age
#116,331
of 264,242 outputs
Outputs of similar age from BMC Health Services Research
#53
of 93 outputs
Altmetric has tracked 22,799,071 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,629 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,242 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.